Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
iShares U.S. Medical Devices ETF (IHI) and First Trust NYSE Arca Biotechnology Index Fund ETF (FBT) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. IHI is less expensive with a Total Expense Ratio (TER) of 0.38%, versus 0.54% for FBT. IHI is down -11.53% year-to-date (YTD) with -$312M in YTD flows. FBT performs better with -5.96% YTD performance, and +$1.10B in YTD flows. Run a side-by-side ETF comparison of IHI and FBT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IHI FBT | -4.11%-5.58% | -11.52%-7.34% | -11.53%-5.96% | -7.06%+15.04% | +9.22%+29.35% | +3.63%+20.07% |
| Flows | IHI FBT | -$136M+$11M | -$422M+$1.10B | -$312M+$1.10B | -$1.18B+$1.09B | -$2.95B+$639M | -$5.01B+$246M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IHI FBT | +15.63%+22.00% | +18.93%+24.20% | +16.67%+19.85% | +18.77%+21.81% |
| Max drawdown | IHI FBT | -14.63%-12.74% | -14.66%-14.81% | -22.87%-19.92% | -33.07%-29.98% |
| Max drawdown duration | IHI FBT | 65d49d | 107d148d | 210d237d | 1646d1243d |
IHI | FBT | |
Last sale 3/13/2026 at 1:30 PM | $54.67 | $192.69 |
| Previous close 03/12/2026 | $54.97 | $193.57 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
IHI | FBT | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
IHI | FBT | |
|---|---|---|
| Last price | $54.67 | $192.69 |
| 1D performance | -0.55% | -0.46% |
| AuM | $3.29 B | $2.22 B |
| E/R | 0.38% | 0.54% |
IHI | FBT | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | iShares | First Trust |
| Benchmark | Dow Jones U.S. Select Medical Equipment Index | NYSE Arca Biotechnology Index |
| N° of holdings | 46 | 28 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | May 1, 2006 | June 19, 2006 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
